Shaun Noorian

And by the way, USP stands for United States Pharmacopeia and NF stands for National Formulary. These are the government bodies that oversee the practice of compounding. And if they've established a compendial certificate of analysis, you can show that that drug has been studied and that it's regarded as safe.

And then there's the third condition, which these drugs may have to be listed within what's known as category one of the 503 bulks list, which is a list of drugs the FDA has deemed safe and efficacious that neither have a USP or NF monograph and haven't been a component of an FDA-approved drug, but are considered safe and have been grandfathered in.

And then there's the third condition, which these drugs may have to be listed within what's known as category one of the 503 bulks list, which is a list of drugs the FDA has deemed safe and efficacious that neither have a USP or NF monograph and haven't been a component of an FDA-approved drug, but are considered safe and have been grandfathered in.

And then there's the third condition, which these drugs may have to be listed within what's known as category one of the 503 bulks list, which is a list of drugs the FDA has deemed safe and efficacious that neither have a USP or NF monograph and haven't been a component of an FDA-approved drug, but are considered safe and have been grandfathered in.

And so these peptides have never been approved, don't contain a USP-NRF monograph, and aren't contained within category one of the five of the Bluxilis. So they've never been legal to be able to be made. Now, a lot of practitioners and company pharmacies have promoted these drugs over the years.

And so these peptides have never been approved, don't contain a USP-NRF monograph, and aren't contained within category one of the five of the Bluxilis. So they've never been legal to be able to be made. Now, a lot of practitioners and company pharmacies have promoted these drugs over the years.

And so these peptides have never been approved, don't contain a USP-NRF monograph, and aren't contained within category one of the five of the Bluxilis. So they've never been legal to be able to be made. Now, a lot of practitioners and company pharmacies have promoted these drugs over the years.

And now we see, finally, the states and federal regulators, the FDA, are taking action against compounding pharmacies for making these peptides because they were never supposed to be made in the first place.

And now we see, finally, the states and federal regulators, the FDA, are taking action against compounding pharmacies for making these peptides because they were never supposed to be made in the first place.

And now we see, finally, the states and federal regulators, the FDA, are taking action against compounding pharmacies for making these peptides because they were never supposed to be made in the first place.

Some of these peptides, while some are very safe and efficacious, others may not be. Some have failed clinical trials. Almost all of them have failed clinical trials, which is why they still have their letter and numbering system. For example, CJC 1295 stands for Conja Chemical, which is the name of the company that created the peptide and was studying it during clinical trials.

Some of these peptides, while some are very safe and efficacious, others may not be. Some have failed clinical trials. Almost all of them have failed clinical trials, which is why they still have their letter and numbering system. For example, CJC 1295 stands for Conja Chemical, which is the name of the company that created the peptide and was studying it during clinical trials.

Some of these peptides, while some are very safe and efficacious, others may not be. Some have failed clinical trials. Almost all of them have failed clinical trials, which is why they still have their letter and numbering system. For example, CJC 1295 stands for Conja Chemical, which is the name of the company that created the peptide and was studying it during clinical trials.

Now, those trials had to be ceased I believe in phase one for that drug because of patient death. And because of these drugs, they have significant effect, especially that one, on growth hormone release.

Now, those trials had to be ceased I believe in phase one for that drug because of patient death. And because of these drugs, they have significant effect, especially that one, on growth hormone release.

Now, those trials had to be ceased I believe in phase one for that drug because of patient death. And because of these drugs, they have significant effect, especially that one, on growth hormone release.

And this is why, you know, until these drugs become FDA approved, the FDA and state boards of pharmacy are not comfortable utilizing these drugs in a regulated... Do you think it's overreach or do you think that they're like, you know...

And this is why, you know, until these drugs become FDA approved, the FDA and state boards of pharmacy are not comfortable utilizing these drugs in a regulated... Do you think it's overreach or do you think that they're like, you know...

And this is why, you know, until these drugs become FDA approved, the FDA and state boards of pharmacy are not comfortable utilizing these drugs in a regulated... Do you think it's overreach or do you think that they're like, you know...

So to talk about peptides and the conspiracy theories, I've heard them all. And if you look at what the state and federal agencies are doing, all they're doing is the same thing they've always done, enforcing the rules and regulations that are currently in place. And so it's just a coincidence that peptides,